Skyepharma – problems solved, price still down
Posted by Graeme in Shares at 12:03 pm on Monday, 2 May 2005
Either the market is simply not prepared to be anything but negative on Skyepharma or I am missing something. The problems with Paxil continue, but Skyepharma has been shielded from the effects of this by a new agreement with Glaxosmithkline’s which gives Skyepharma the royalties on the budgeted sales until normal sales resume.
(more…)
Feed